NCT01081756View on ClinicalTrials.gov

A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET)

PHASE3CompletedINTERVENTIONAL

Enrollment

218

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

September 30, 2004

Conditions

Infertility

Interventions

DRUG

r-hCG

r-hCG (250 mcg) injection subcutaneously (s.c.) or intramuscularly (i.m.)

DRUG

Urinary-hCG

Urinary hCG (10,000 IU) injection s.c. or i.m.

Trial Locations (1)

100191

Peking University 3rd Hopistal, Beijing

All Listed Sponsors

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01081756 - A Study Using Recombinant Human Chorionic Gonadotrophin (rhCG, Ovidrel®) in the Induction of Final Follicle Maturation and Early Luteinization in Chinese Women Undergoing in Vitro Fertilization and Embryo Transfer (IVF/ET) | Biotech Hunter | Biotech Hunter